Q1 2023 Holdings
Filed 2023-05-15 | 91 holdings | $180.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $17.9M | 1,347,088 | 9.9% |
| Novocure LTDCall | CALL | G6674U908 | $9.7M | 161,500 | 5.4% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $9.5M | 2,870,000 | 5.3% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $8.2M | 1,132,000 | 4.5% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $7.1M | 305,000 | 3.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $5.4M | 185,000 | 3.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $5.4M | 620,000 | 3.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $4.6M | 150,000 | 2.6% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $4.6M | 500,000 | 2.5% |
| Glaukos Corp(GKOS) | COM | 377322102 | $4.6M | 91,000 | 2.5% |
| Penumbra Inc(PEN) | COM | 70975L107 | $4.5M | 16,000 | 2.5% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $4.2M | 270,000 | 2.3% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $4.2M | 180,000 | 2.3% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $4.2M | 240,000 | 2.3% |
| Akoya Biosciences Inc | COM | 00974H104 | $4.1M | 500,000 | 2.3% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $4.0M | 6,227,559 | 2.2% |
| Resmed Inc(RMD) | COM | 761152107 | $3.7M | 17,000 | 2.1% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $3.6M | 850,000 | 2.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $3.6M | 260,000 | 2.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $3.2M | 35,000 | 1.8% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $3.2M | 130,000 | 1.8% |
| Mersana Therapeutics IncCall | CALL | 59045L906 | $3.1M | 750,100 | 1.7% |
| Varex Imaging Corp(VREX) | COM | 92214X106 | $3.0M | 165,000 | 1.7% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $2.9M | 12,500 | 1.6% |
| Koru Medical Systems Inc(KRMD) | COM | 759910102 | $2.9M | 685,002 | 1.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $2.6M | 148,000 | 1.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.6M | 155,000 | 1.4% |
| Mimedx Group Inc(MDXG) | COM | 602496101 | $2.6M | 748,000 | 1.4% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $2.2M | 225,992 | 1.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $2.2M | 286,000 | 1.2% |
| Illumina Inc(ILMN) | COM | 452327109 | $2.1M | 9,000 | 1.2% |
| TG Venture Acquisition Corp | CLASS A COM | 87251T109 | $2.1M | 200,000 | 1.1% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $2.1M | 178,000 | 1.1% |
| Biolinerx LTD | SPONSORED ADS | 09071M205 | $2.0M | 2,279,657 | 1.1% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $2.0M | 505,781 | 1.1% |
| Cvrx Inc(CVRX) | COM | 126638105 | $1.9M | 205,000 | 1.1% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $1.8M | 55,000 | 1.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.8M | 155,000 | 1.0% |
| Silk RD MED Inc | COM | 82710M100 | $1.8M | 45,000 | 1.0% |
| Genedx Holdings Corp(SMFRUSD) | COM CL A | 81663L101 | $1.7M | 4,588,000 | 0.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $1.6M | 43,000 | 0.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $1.6M | 100,000 | 0.9% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $1.6M | 228,714 | 0.9% |
| Ault Disruptive Techs Corp | COM | 05150A104 | $1.6M | 150,000 | 0.9% |
| Western Acqstn Ventures Corp | COM | 95758L107 | $1.0M | 100,000 | 0.6% |
| Pepperlime Health Acqustn Co | CLASS A ORD SHS | G70021103 | $1.0M | 100,000 | 0.6% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $1.0M | 112,614 | 0.6% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $979.5K | 30,000 | 0.5% |
| FAT Brands Inc | *W EXP 07/16/202 | 30258N121 | $896.7K | 227,000 | 0.5% |
| Coliseum Acquisition Corp | CLASS A ORD SHS | G2263T123 | $872.1K | 85,000 | 0.5% |